The current study evaluated whether baseline acute and chronic prostate inflammation among men with an initial negative biopsy for prostate cancer increases the risk of subsequent cancer detection in a clinical trial with systematic biopsies. The results indicated that inflammation in negative biopsies for prostate cancer might lower the risk of subsequent cancer detection.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf